Mindset Pharma Stock Number Of Employees
| MSSTFDelisted Stock | USD 0.36 0.00 0.00% |
Mindset Pharma fundamentals help investors to digest information that contributes to Mindset Pharma's financial success or failures. It also enables traders to predict the movement of Mindset OTC Stock. The fundamental analysis module provides a way to measure Mindset Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mindset Pharma otc stock.
Mindset |
Mindset Pharma OTC Stock Number Of Employees Analysis
Mindset Pharma's Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Current Mindset Pharma Number Of Employees | 6 |
Most of Mindset Pharma's fundamental indicators, such as Number Of Employees, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mindset Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Employee typically refers to an individual working under a contract of employment, whether oral or written, express or implied, and has recognized his or her rights and duties. Most officers of corporations are included as employees and contractors are generally excluded.
CompetitionBased on the recorded statements, Mindset Pharma is currently employing 6.0 people. This is 99.95% lower than that of the Healthcare sector and 98.88% lower than that of the Biotechnology industry. The number of employees for all United States stocks is 99.97% higher than that of the company.
Mindset Number Of Employees Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mindset Pharma's direct or indirect competition against its Number Of Employees to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Mindset Pharma could also be used in its relative valuation, which is a method of valuing Mindset Pharma by comparing valuation metrics of similar companies.Mindset Pharma is currently under evaluation in number of employees category among its peers.
Mindset Fundamentals
| Return On Equity | -2.43 | |||
| Return On Asset | -0.48 | |||
| Profit Margin | (1.64) % | |||
| Operating Margin | (1.33) % | |||
| Current Valuation | 19.22 M | |||
| Shares Outstanding | 95.25 M | |||
| Shares Owned By Insiders | 9.00 % | |||
| Shares Owned By Institutions | 0.88 % | |||
| Price To Book | 28.87 X | |||
| Price To Sales | 4.83 X | |||
| Revenue | 3.91 M | |||
| Gross Profit | 3.91 M | |||
| EBITDA | (16.53 M) | |||
| Net Income | (16.61 M) | |||
| Cash And Equivalents | 8.71 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 171.79 K | |||
| Debt To Equity | 0.12 % | |||
| Current Ratio | 1.18 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | 385.56 K | |||
| Earnings Per Share | (0.19) X | |||
| Target Price | 5.02 | |||
| Beta | -0.28 | |||
| Market Capitalization | 20.95 M | |||
| Total Asset | 9.77 M | |||
| Z Score | 69.3 | |||
| Net Asset | 9.77 M |
About Mindset Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mindset Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mindset Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mindset Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Mindset OTC Stock
If you are still planning to invest in Mindset Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mindset Pharma's history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |